Vascular endothelial growth factor (VEGF), including its variant VEGF165, in the microenvironment acts through an isoform-specific receptor, neuropilin-1 (NRP1), to attract the movement of cancer cells and is similar to neutrophil chemoattractant movements2–5. This evidence concerns the gene NRP1 and cancer.